Search results
Results from the WOW.Com Content Network
COVID-19 vaccine clinical research uses clinical research to establish the characteristics of COVID-19 vaccines. These characteristics include efficacy , effectiveness , and safety. As of November 2022 [update] , 40 vaccines are authorized by at least one national regulatory authority for public use: [ 1 ] [ 2 ]
The We-Care project is a novel initiative by University of California, Davis researchers that uses anonymity and crowdsourced information to alert infected users and slow the spread of COVID-19. [58] [59] [60] The scientific community has held several machine learning competitions to identify false information related to the COVID-19 pandemic ...
Comparing immunogenicity results of Nanocovax with those of COVID-19 convalescent patients evaluated by the Pasteur Institute in Ho Chi Minh City, as well as with the immunological results from other licensed vaccines, it was shown that the Nanocovax vaccine is effective in preventing COVID-19.
Razi Cov Pars (Persian: رازی کوو پارس) is a COVID-19 vaccine developed by the Iranian Razi Vaccine and Serum Research Institute Razi Cov Pars is a covid-19 vaccine based on recombinant protein, which is being produced by Razi Vaccine and Serum Research Institute, Iran. This vaccine is the first injectable-intranasal recombinant ...
The Canadian government announced CA$275 million in funding for 96 research projects on medical countermeasures against COVID-19, including numerous vaccine candidates at Canadian universities, [179] [180] with plans to establish a "vaccine bank" of new vaccines for implementation if another COVID-19 outbreak occurs.
Vaccines. History; Research. VITT; ... Misinformation and hesitancy. US; Vaccine card; Vaccine passports; Current vaccines ... West China Hospital COVID-19 vaccine is ...
COVI-VAC (codenamed CDX-005) is a COVID-19 vaccine developed by Codagenix, Inc. In December 2020, COVI-VAC started a Phase I clinical trial , involving 48 participants. The trial was scheduled to complete in June 2021, with results to be reported by May 2022.
Research has been working on clinical use since the 1990s, with significant success in cancer therapy in the early 2010s. [1] In 2020 and 2021, mRNA vaccines have been developed globally for use in combating the coronavirus disease (COVID-19 pandemic). [2]